Should I Buy Bristol Myers Squibb (BMY)? Finance YouTuber Analysis
VERDICT: STRONG BUY 0/100
Get weekly updates on this stock
“The analyst believes Bristol-Myers Squibb is a 'trifecta' opportunity due to its growing earnings, share buybacks, and potential for market multiple…”
Financials
Reported figures · last 5 yearsCall record — BMY
10 CALLS · 5 BUY / 0 SELL / 0 WATCHCreate a free account to see every call — who, when, at what price.
Each call is dated, linked to the source video, and graded. Free accounts see the full record.
FAQ
Should I buy Bristol Myers Squibb?
5 finance YouTubers analysed Bristol Myers Squibb with qualified reasoning — consensus: Buy, average analysis quality 69/100. This is not financial advice; review the individual analyses and sources above.
Are finance YouTubers bullish or bearish on Bristol Myers Squibb?
Among the channels covering Bristol Myers Squibb, 5 are buying and 0 are selling or avoiding — overall Buy.
What price target do YouTubers give Bristol Myers Squibb?
The price targets mentioned for Bristol Myers Squibb range 61.9–103. Targets are the YouTubers' own; not a guarantee.
How do you decide what to include for Bristol Myers Squibb?
Only qualified analyses count: a clear buy/sell stance on Bristol Myers Squibb with real reasoning (valuation, fundamentals, a catalyst or a chart setup). Passing mentions are excluded.